Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Post by Valuehunter72on Jun 26, 2020 10:14am
148 Views
Post# 31194769

This Was So Good

This Was So GoodIt needs reposting. Compliments of 359. #1----WHY has there been no approval from the tsxv on this placement as we enter the 31st day. #2--WHY has no insider buying taken place as yet , especially the CEO DAVID GOREN who at this time has zero shares in this company---#3--WHY after ground breaking news and moving in to one of the top medical centres in ISRAEL and trading with highs of .335 and .175 cents did the company manipulate the stock down to .075 and now .09 on a good day. ---#4---WHY after getting funding approval from the govt . and trading at .175 did the company feel that .085 was an offering price instead of .15 with 50% less dilution to retail shareholders----#5--WHY are shareholders on ceo.ca so afraid to ask those questions and if you do ask them the abuse you take becomes an obstacle to fair opinion.----
<< Previous
Bullboard Posts
Next >>